Testosterone Cypionate Injections Recalled for Sterility Assurance Failure
Tailor Made Compounding recalls Testosterone Cypionate injections due to lack of sterility assurance. The recall affects 4,219 vials distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall without reported illnesses or injuries in the source text. The hazard—lack of sterility assurance in an injectable drug—represents a risk-of-harm product where injury has not yet been reported. Per the severity rubric, this qualifies as High severity (Score 3).
Plain-English summary
Tailor Made Compounding is recalling Testosterone Cypionate 200mg/ml injectable solution in multiple vial sizes (2mL, 4mL, 5mL, and 10mL) due to a lack of assurance of sterility. The affected batches were distributed nationwide throughout the United States and Puerto Rico.
The recall was initiated because Tailor Made Compounding could not assure that the products met required sterility standards for injectable medications. This poses a potential risk to patients who receive these injections, as non-sterile products could introduce harmful bacteria or other microorganisms.
A total of 4,219 vials across multiple batch numbers and expiration dates are included in this recall. The affected batch numbers and expiration dates are listed in the FDA recall notice.
Patients who have received injections from the recalled batches should contact their healthcare provider. Healthcare providers should identify patients who may have received the recalled product and follow appropriate monitoring and treatment protocols if needed.
The recalled product
- Product
- Testosterone Cypionate (GSO) 200mg/ml a) 2 mL-vial, b) 4 mL-vial, c) 5 mL-vial, d) 10 mL-vial, Room temperature, Tailor Made Compounding
- Manufacturer
- TMC Acquisition LLC dba Tailor Made Compounding
- Category
- Drug
- Hazard
- sterility-assurance
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Batch#: a)12212105A2
- Exp 6/19/2022
- 02182229A1
- Exp 8/17/2022
- b) 12012121A2
- Exp 5/30/2022
- 12212104A2
- 01242216A2
- Exp 7/23/2022
- 02182236A1
- c) 12072133A1
- Exp 6/5/2022
- 01192225A1
- Exp 7/18/2022
- 02182228A1
- d)10142105A
- Exp 4/12/2022
- 10272105A1
- Exp 4/25/2022
- 11102101A1
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27